Mr. Grego is the managing partner and CIO of Quintessential Capital Management (QCM), a long/short equity fund based in New York City. Quintessential focuses on activist investing and has built an impressive track record in identifying, investigating and exposing fraud and other corporate malfeasance.
Among its notable successes, Quintessential shorted and exposed the notorious “Globo Plc”, “Folli Follie” and Bio-on, all of which were confirmed frauds and delisted within days of QCM report. QCM also exposed the Canadian cannabis company “Aphria”, highlighting serious conflicts of interest leading to the resignation of the entire board CEO included.
On the long side, QCM has called for the management of Allergan (a $30b+ pharmaceutical company) to step down and put the company up for sale: the company was sold to AbbVie three weeks later.
Quintessential operates through a so-called “deep due diligence” approach, applying state-of-the-art investigative techniques to supplement its more traditional fundamental analysis.